t.tulloch
TL2 Moderator · Antalya
Contributes reviews on supplier material. Based in Antalya.
Joined 12 April 2025 · last posted 6h
90 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #47 · Clinical › Bloodwork · 28 Jul 2026 · 3 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #86 · Meta › Announcements · 20 Jul 2026 · 19 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tracking a shortage from primary sources rather than rumour Replied, post #97 · Access › Shortages · 11 Jul 2026 · 29 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #20 · Practice › Interactions · 7 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #23 · Evidence › Journal club · 4 Jul 2026 · 24 likes Picking up post #20: that is the part I would want checked first. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #53 · Compounds › Repair & healing peptides · 4 Jul 2026 · 7 likes Worth separating two things that post #49 runs together. For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence…
-
Prescription portability between countries Replied, post #80 · Access › International · 28 Jun 2026 · 4 likes On post #76 — agreed on the reasoning, with one qualification. Insurance and coverage: coverage decisions are national. A compound approved in one country might not be…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #34 · Outcomes › Body composition · 28 Jun 2026 · 0 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #86 · Safety › Contraindications · 25 Jun 2026 · 18 likes Worth separating two things that post #82 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Reading a trial's population section before its results Replied, post #98 · Evidence › Trials · 7 Jun 2026 · 26 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #35 · Evidence › Journal club · 5 Jun 2026 · 15 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #19 · Pharmacology › Pharmacokinetics · 31 May 2026 · 21 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #105 · Compounds › Tirzepatide · 30 May 2026 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The anatomy of a question that gets answered within an hour Replied, post #50 · Start Here › How to Ask · 19 May 2026 · 19 likes post #49 is right about the mechanism and I think understates the practical bit. Disagreeing with an answer you got: cite what you disagree with, say what contradicts…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #103 · Practice › Reconstitution · 29 Apr 2026 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #13 · Pharmacology › Formulation chemistry · 11 Apr 2026 · 6 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
-
Follow-up: State-level differences that actually matter Replied, post #92 · Regional › North America · 8 Apr 2026 · 27 likes Coming back to post #90, because the follow-up matters more than the original answer. Private insurance gaps: some people have private insurance but medication is not…
-
Journal club: is percentage weight change the right endpoint? Replied, post #40 · Evidence › Journal club · 5 Apr 2026 · 3 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Preprint servers and what screening they do Replied, post #102 · Evidence › Preprints · 25 Mar 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Anaesthesia and elective surgery: the aspiration question Replied, post #57 · Practice › Interactions · 20 Mar 2026 · 15 likes On post #53 — agreed on the reasoning, with one qualification. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #70 · Clinical › Special populations · 12 Mar 2026 · 0 likes Coming back to post #68, because the follow-up matters more than the original answer. Hepatic impairment: less is known about dosing in significant liver disease than…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #129 · Practice › Interactions · 10 Mar 2026 · 0 likes Coming back to post #127, because the follow-up matters more than the original answer. Metformin: commonly co-administered and relevant to gastrointestinal…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #3 · Evidence › Journal club · 5 Mar 2026 · 9 likes On the opening post — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #2 · Evidence › Journal club · 28 Feb 2026 · 28 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Adolescents: a distinct evidence base — one year on Replied, post #69 · Clinical › Special populations · 27 Feb 2026 · 18 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
-
MHRA statements, read directly Replied, post #93 · Regional › UK & Ireland · 20 Feb 2026 · 5 likes Ireland: the Health Products Regulatory Authority implements EU framework. Prescription-only. Reimbursement for weight management has been more restrictive than for…
-
Reading an interaction checker output critically Replied, post #114 · Practice › Interactions · 8 Feb 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #15 · Practice › Administration · 31 Jan 2026 · 5 likes Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost a "meaningful" dose depends on concentration and your…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #28 · Pharmacology › Pharmacokinetics · 30 Jan 2026 · 5 likes On post #24 — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
Cost per delivered dose, which is the number that matters Replied, post #42 · Access › Pricing · 25 Jan 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #11 · Practice › Side effects · 13 Jan 2026 · 2 likes post #10 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #52 · Compounds › Semaglutide · 5 Jan 2026 · 26 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #16 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 2 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #2 · Practice › Administration · 20 Dec 2025 · 0 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #37 · Pharmacology › Pharmacokinetics · 13 Dec 2025 · 7 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Meeting a protein target on a suppressed appetite Replied, post #41 · Nutrition & Training › Protein & intake · 10 Dec 2025 · 27 likes Coming back to post #39, because the follow-up matters more than the original answer. Fibre: adequate fibre intake supports fullness and gut motility, both of which…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #51 · Compounds › Tirzepatide · 7 Dec 2025 · 1 like SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Prescription requirements and telehealth models Replied, post #50 · Sourcing › Regulatory · 6 Dec 2025 · 7 likes Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #63 · Practice › Interactions · 5 Dec 2025 · 12 likes post #62 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #37 · Analytics › Impurities & related substances · 21 Nov 2025 · 14 likes Disulfide formation: if a peptide contains cysteine, it can form disulfide bonds with itself or with other molecules. Under oxidising conditions multiple species…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile… Replied, post #8 · Compounds › Semaglutide · 11 Nov 2025 · 4 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
What a purity-only report leaves out Replied, post #48 · Sourcing › Independent verification · 15 Oct 2025 · 0 likes I read post #46 twice before replying, because I had assumed the opposite. Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #78 · Practice › Reconstitution · 14 Oct 2025 · 1 like post #77 is right about the mechanism and I think understates the practical bit. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands…
-
New subcategory: rationale and scope Replied, post #15 · Meta › Announcements · 13 Oct 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #101 · Analytics › HPLC & UHPLC · 10 Oct 2025 · 0 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #109 · Evidence › Preprints · 4 Oct 2025 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Gauge and length selection for subcutaneous injection Replied, post #33 · Devices › Syringes & needles · 25 Sep 2025 · 17 likes post #32 answers the question as asked. The question underneath it is different. Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #26 · Data & Tools › Datasets · 7 Sep 2025 · 28 likes Picking up post #23: that is the part I would want checked first. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #83 · Evidence › Journal club · 7 Sep 2025 · 0 likes This follows post #80 rather than contradicting it. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #68 · Evidence › Journal club · 2 Sep 2025 · 9 likes On post #64 — agreed on the reasoning, with one qualification. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
A ten-fold dose error caught before injection Replied, post #89 · Devices › Syringes & needles · 27 Aug 2025 · 0 likes Worth separating two things that post #85 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #22 · Evidence › Journal club · 12 Aug 2025 · 2 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Travel coolers and how long they really hold Replied, post #72 · Devices › Cold chain · 7 Aug 2025 · 0 likes This follows post #69 rather than contradicting it. Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if…
-
When a preprint is the best available evidence and we say so Replied, post #23 · Evidence › Preprints · 4 Aug 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
How to research a compound with no human data without deceiving yourself Replied, post #10 · Compounds › Other compounds · 30 Jul 2025 · 31 likes Coming back to post #8, because the follow-up matters more than the original answer. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that…
-
[2026 update] Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Started this topic · Compounds › Tirzepatide · 28 Jul 2025 · 25 likes Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021)…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #40 · Analytics › Home & field testing · 19 Jul 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #13 · Analytics › Method validation · 16 Jul 2025 · 20 likes Coming back to post #11, because the follow-up matters more than the original answer. Limits of detection and quantitation: LOD is the lowest concentration that…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #5 · Start Here › Welcome · 21 Jun 2025 · 14 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Antibiotics and a course of something with delayed emptying Replied, post #67 · Practice › Interactions · 17 Jun 2025 · 21 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #61 · Access › Insurance & coverage · 11 Jun 2025 · 25 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Pregnancy as an absolute contraindication Replied, post #57 · Safety › Contraindications · 19 May 2025 · 7 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #41 · Outcomes › Body composition · 14 May 2025 · 21 likes This follows post #38 rather than contradicting it. Ultrasound: thickness of subcutaneous fat at specific sites. Less standardised than DXA and operator-dependent.…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #55 · Data & Tools › Calculators · 7 May 2025 · 25 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Lean mass preservation: what the evidence supports Started this topic · Outcomes › Body composition · 1 May 2025 · 61 likes Lean mass preservation: what the evidence supports Writing it up because I had to work it out twice and would rather nobody else did. Maintenance rather than loss,…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #83 · Evidence › Journal club · 21 Apr 2025 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: What other technical communities get right that we do not Replied, post #71 · Lounge › Off topic · 18 Apr 2025 · 13 likes Picking up post #68: that is the part I would want checked first. Politics and public policy: healthcare policy that affects access to these compounds is relevant here.…
-
Sequence verification for an obscure compound: how it is done Replied, post #7 · Compounds › Other compounds · 6 Apr 2025 · 15 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #52 · Compounds › Semaglutide · 25 Mar 2025 · 4 likes post #51 is right about the mechanism and I think understates the practical bit. The opalescent appearance in semaglutide solutions is occasionally noted and the…
-
Validating a method you did not develop — does this still hold? Replied, post #144 · Analytics › Method validation · 21 Mar 2025 · 28 likes Precision and repeatability: within-run and between-run variability of the method. Acceptance criterion is typically a relative standard deviation of ≤2% for area…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #147 · Sourcing › Vendor reports · 19 Mar 2025 · 20 likes post #146 is right about the mechanism and I think understates the practical bit. Date the report: when the analysis was done matters. Material can degrade in storage.…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #33 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes Picking up post #30: that is the part I would want checked first. Pattern across lots: a single result is a data point. Three or four results from the same supplier…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #5 · Devices › Syringes & needles · 10 Mar 2025 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard),…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #97 · Data & Tools › Calculators · 19 Feb 2025 · 20 likes post #96 is right about the mechanism and I think understates the practical bit. Dose equivalence calculator: compounds have different potencies. The calculator is…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #12 · Practice › Reconstitution · 12 Jan 2025 · 0 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #33 · Compounds › Oral incretins · 9 Jan 2025 · 0 likes post #32 is right about the mechanism and I think understates the practical bit. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type…
-
Isotonicity and what happens when you get it wrong Replied, post #21 · Pharmacology › Formulation chemistry · 8 Jan 2025 · 0 likes post #20 is right about the mechanism and I think understates the practical bit. Excipients and their purposes: mannitol, sucrose, or other sugars in lyophilised…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #29 · Safety › Adverse events · 21 Dec 2024 · 3 likes Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance…
-
Building a sensible monitoring schedule with your prescriber Replied, post #49 · Clinical › Bloodwork · 20 Dec 2024 · 5 likes Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and weight. A small change in creatinine might not mean a real change in kidney…
-
Coming back to: When to suspect the method rather than the sample Replied, post #100 · Analytics › Method validation · 19 Dec 2024 · 3 likes On post #96 — agreed on the reasoning, with one qualification. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately…
-
What we do not know about retatrutide, listed explicitly Replied, post #18 · Compounds › Retatrutide · 11 Dec 2024 · 7 likes Worth separating two things that post #14 runs together. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material…
-
[2026 update] New subcategory: rationale and scope Replied, post #30 · Meta › Announcements · 29 Nov 2024 · 18 likes Picking up post #27: that is the part I would want checked first. When announcements are made: major policy changes, technical changes affecting site function, planned…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #14 · Sourcing › Vendor reports · 21 Nov 2024 · 11 likes post #13 answers the question as asked. The question underneath it is different. Structured report format: compound, lot, independent testing service, method as…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #9 · Nutrition & Training › Protein & intake · 17 Nov 2024 · 29 likes Picking up post #6: that is the part I would want checked first. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain…
-
Time to steady state after a dose increase Replied, post #42 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 20 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…
-
Identical chromatograms across two different lots Replied, post #37 · Sourcing › Red flags · 15 Oct 2024 · 10 likes post #36 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Blind submission and why it changes minds Replied, post #78 · Sourcing › Independent verification · 4 Oct 2024 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #35 · Evidence › Journal club · 5 Sep 2024 · 3 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #30 · Compounds › Semaglutide · 31 Aug 2024 · 3 likes Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they stopped at 2.4 mg. Some people report trying higher doses, but…
-
Assessing a warm arrival: the decision process — one year on Replied, post #128 · Sourcing › Logistics · 2 Jun 2024 · 0 likes Worth separating two things that post #124 runs together. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…